Erratum to NOTCH alteration in EGFR-mutated lung adenocarcinoma leads to histological small-cell carcinoma transformation under EGFR-TKI treatment
Erratum to: Transl Lung Cancer Res 2021;10:4161-73
This article (1) titled “NOTCH alteration in EGFR-mutated lung adenocarcinoma leads to histological small-cell carcinoma transformation under EGFR-TKI treatment” (doi: 10.21037/tlcr-21-536), unfortunately contains an error in Figure 4. Between Adenocarcinoma and Small Cell Carcinoma in the lower part of the figure, NOTCH expression decreased and ASCL expression increased, which mean the direction of the 2 arrows are reversed. The correct illustration is that, between Adenocarcinoma and Small Cell Carcinoma in the lower part of the figure, the NOTCH arrow points down and the ASCL arrow points up. The corrected Figure 4 can be found below.
Corrected Figure 4:
The authors apologize for the oversight.
Click here to view the updated version of the article.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Koba H, Kimura H, Yoneda T, et al. NOTCH alteration in EGFR-mutated lung adenocarcinoma leads to histological small-cell carcinoma transformation under EGFR-TKI treatment. Transl Lung Cancer Res 2021;10:4161-73. [Crossref] [PubMed]
